FR2746314B1 - Produit contenant du milnacipran et de l'idazoxan comme preparation pharmaceutique combinee - Google Patents

Produit contenant du milnacipran et de l'idazoxan comme preparation pharmaceutique combinee

Info

Publication number
FR2746314B1
FR2746314B1 FR9603674A FR9603674A FR2746314B1 FR 2746314 B1 FR2746314 B1 FR 2746314B1 FR 9603674 A FR9603674 A FR 9603674A FR 9603674 A FR9603674 A FR 9603674A FR 2746314 B1 FR2746314 B1 FR 2746314B1
Authority
FR
France
Prior art keywords
idazoxan
pharmaceutical preparation
product containing
combined pharmaceutical
containing milnacipran
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9603674A
Other languages
English (en)
Other versions
FR2746314A1 (fr
Inventor
Francis Colpaert
Marc Marien
Wouter Koek
Thierry Imbert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Priority to FR9603674A priority Critical patent/FR2746314B1/fr
Priority to AU25119/97A priority patent/AU2511997A/en
Priority to PCT/FR1997/000522 priority patent/WO1997035574A1/fr
Publication of FR2746314A1 publication Critical patent/FR2746314A1/fr
Application granted granted Critical
Publication of FR2746314B1 publication Critical patent/FR2746314B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR9603674A 1996-03-25 1996-03-25 Produit contenant du milnacipran et de l'idazoxan comme preparation pharmaceutique combinee Expired - Fee Related FR2746314B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR9603674A FR2746314B1 (fr) 1996-03-25 1996-03-25 Produit contenant du milnacipran et de l'idazoxan comme preparation pharmaceutique combinee
AU25119/97A AU2511997A (en) 1996-03-25 1997-03-25 Composition containing milnacipran and idazoxan for use as combined pharmaceutical preparation
PCT/FR1997/000522 WO1997035574A1 (fr) 1996-03-25 1997-03-25 Produit contenant du milnacipran et de l'idazoxan comme preparation pharmaceutique combinee

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9603674A FR2746314B1 (fr) 1996-03-25 1996-03-25 Produit contenant du milnacipran et de l'idazoxan comme preparation pharmaceutique combinee

Publications (2)

Publication Number Publication Date
FR2746314A1 FR2746314A1 (fr) 1997-09-26
FR2746314B1 true FR2746314B1 (fr) 1998-06-12

Family

ID=9490503

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9603674A Expired - Fee Related FR2746314B1 (fr) 1996-03-25 1996-03-25 Produit contenant du milnacipran et de l'idazoxan comme preparation pharmaceutique combinee

Country Status (3)

Country Link
AU (1) AU2511997A (fr)
FR (1) FR2746314B1 (fr)
WO (1) WO1997035574A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6635675B2 (en) 2001-11-05 2003-10-21 Cypress Bioscience, Inc. Method of treating chronic fatigue syndrome
US6602911B2 (en) 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
NZ541733A (en) 2003-02-14 2009-03-31 Pf Medicament Use of the enantiomer (1S,2R) of milnacipran for the preparation of a medicament
FR2851163B1 (fr) 2003-02-14 2007-04-27 Utilisation de l'enantiomere dextrogyre du milnacipran pour la preparation d'un medicament
US7595335B2 (en) 2003-10-28 2009-09-29 Pierre Fabre Medicament Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof
FR2861299B1 (fr) 2003-10-28 2006-01-27 Pf Medicament Compositions pharmaceutiques a base de derives d'idasoxan sous formes polymorphes
US8476307B2 (en) 2003-10-28 2013-07-02 Pierre Fabre Medicament Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof
WO2006083204A1 (fr) * 2004-12-27 2006-08-10 Alpha 2 Pharmaceutical Ab Medicament antidepresseur comprenant idazoxan et inhibiteur selectif du recaptage de la serotonine
JP2013510176A (ja) 2009-11-06 2013-03-21 ピエール ファーブル メディカモン （１ｓ，２ｒ）−２−（アミノメチル）−ｎ，ｎ−ジエチル−１−フェニルシクロプロパンカルボキサミドの新規結晶形態
US20120289744A1 (en) 2010-11-03 2012-11-15 Arch Pharmalabs Limited Process for preparing optically pure milnacipran and its pharmaceutically acceptable salts

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124346A (en) * 1991-04-23 1992-06-23 Pfizer Inc. Synergistic combinations in the treatment of anxiety
US5492907A (en) * 1992-12-09 1996-02-20 The United States Of America As Represented By The Department Of Health & Human Services Antipsychotic composition and method of treatment
CA2134038C (fr) * 1994-06-16 1997-06-03 David Taiwai Wong Potentialisation des effets de medicaments

Also Published As

Publication number Publication date
WO1997035574A1 (fr) 1997-10-02
FR2746314A1 (fr) 1997-09-26
AU2511997A (en) 1997-10-17

Similar Documents

Publication Publication Date Title
MA26568A1 (fr) Association d'un inhibiteur d'aldose-reductase et d'un inhibiteur de glycogene-phosphorylase et composition pharmaceutique la contenant
FR2800041B1 (fr) Ensemble de conditionnement et d'application d'un produit liquide
FR2734483B1 (fr) Forme d'administration pharmaceutique comprenant de l'oxybutynine
MA23895A1 (fr) Amides therapeutiques et compositions les contenant
EP0944737A4 (fr) Representations d'interactions bimoleculaires
FR2736248B1 (fr) Ensemble d'application de produit de consistance pateuse tel que du rouge a levres
FR2703993B1 (fr) Utilisation en cosmétique de dérivés lipophiles des amino déoxyalditols, compositions cosmétiques les contenant, et nouveaux carbamates d'alkyle.
DK0850059T3 (da) Farmaceutiske formuleringer indeholdende darifenacin
MA26563A1 (fr) Composes therapeutiquement actifs contenant de l'indazole en remplacement bio-isosterique du catechol, leur preparation et composition pharmaceutique les contenant
DZ2538A1 (fr) Tartrate d'un dipeptide substitué procédé pour sa préparation et compositions pharmaceutiques le contenant.
MA26426A1 (fr) Procedes et intermediaires pour la preparation de b-lactames monocycliques nouveaux et pour compositions pharmaceutiques les contenant
FR2771907B1 (fr) Ensemble de conditionnement et d'application d'un produit, notamment cosmetique
MA26586A1 (fr) Association pharmaceutique pour le traitement d'un dysfonctionnement sexuel et compositions la contenant
FR2737408B1 (fr) Utilisation d'un antagoniste de bradykinine dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
FR2736261B1 (fr) Produit d'hygiene capillaire ou de traitement pileux
FR2733908B1 (fr) Utilisation d'extraits de graines de cassia et/ou de trigonelle enrichis en galactomannanes et produit cosmetique ou pharmaceutique, notamment dermatologique, contenant de tels extraits
FR2742657B1 (fr) Compositions pour le traitement des matieres keratiniques contenant l'association d'un polymere polyampholyte et d'un polymere cationique
FR2781676B1 (fr) Trimere du produit d'expression du gene env de hiv
FR2730409B1 (fr) Utilisation des galactolipides, en particulier galactosylglycerides, et des extraits d'origine naturelle contenant ces produits, dans les domaines cosmetiques, pharmaceutique et notamment dermatologique
FR2730995B1 (fr) Composes bi-aromatiques derives d'amide, compositions pharmaceutiques et cosmetiques les contenant et utilisations
GB9515279D0 (en) Improved therapeutic agents
FR2725898B1 (fr) Produit pour application topique contenant une lipase et un precurseur d'hydroxyacide
TNSN97125A1 (fr) Composes furanne-nitrone
FR2752422B1 (fr) Composition pharmaceutique contenant des acides 4-oxo-butanoiques
FR2735981B1 (fr) Composition cosmetique ou pharmaceutique contenant un extrait de plante du genre foetidia

Legal Events

Date Code Title Description
ST Notification of lapse